Basit öğe kaydını göster

dc.contributor.authorSelçuk, I.
dc.contributor.authorMeydanlı, M. M.
dc.contributor.authorYalçın, I.
dc.contributor.authorGüngördük, Kemal
dc.contributor.authorAkgol, S.
dc.contributor.authorCelik, H.
dc.contributor.authorAyhan, A.
dc.date.accessioned2020-11-20T14:40:38Z
dc.date.available2020-11-20T14:40:38Z
dc.date.issued2019
dc.identifier.issn1048-891X
dc.identifier.issn1525-1438
dc.identifier.urihttps://doi.org/10.1136/ijgc-2019-ESGO.38
dc.identifier.urihttps://hdl.handle.net/20.500.12809/781
dc.descriptionWOS: 000523502500039en_US
dc.description.abstractThe aim of this study was to analyze the survival outcomes of stage IIIC ovarian high-grade serous carcinoma (HGSC) patients with both peritoneal and lymphatic dissemination (IP(+)/RP(+)) who had undergone maximal or optimal cytoreduction followed by intravenous carboplatin/paclitaxel chemotherapy to those women with stage IIIC ovarian HGSC who have only peritoneal involvement (IP(+)/RP(-)) treated similarly.en_US
dc.item-language.isoengen_US
dc.publisherBmj Publishing Groupen_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGynecologic Oncologyen_US
dc.titleCOMPARISON OF SURVIVAL OUTCOMES IN OPTIMALLY OR MAXIMALLY CYTOREDUCTED STAGE IIIC OVARIAN HIGH-GRADE SEROUS CARCINOMA: WOMEN WITH ONLY PERITONEAL TUMOR BURDEN VERSUS WOMEN WITH BOTH PERITONEAL AND LYMPHOGENOUS DISSEMINATIONen_US
dc.item-typeconferenceObjecten_US
dc.contributor.departmentMÜ, Eğitim ve Araştırma Hastanesien_US
dc.contributor.institutionauthorGüngördük, Kemal
dc.identifier.volume29en_US
dc.identifier.startpageA36en_US
dc.identifier.endpageA36en_US
dc.relation.journalInternational Journal of Gynecological Canceren_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster